To investigate the myocardially protective effects of Salvia miltiorrhiza injection in streptozotocininduced diabetic rats and the possible mechanisms involved. METHODS: Adult male Sprague-Dawley rats were randomized into three groups (n = 10 per group): diabetes, no treatment (Sm-); diabetes, S. miltiorrhiza injection (Sm+); control (no diabetes; saline treatment). After model induction and 4 weeks' treatment, heart function of five rats from each group was tested by Langendorff isolated in vivo heart perfusion. In the remaining rats, pathological changes of the myocardium were observed by haematoxylin and eosin staining, and protein levels of thrombospondin-1 (TSP-1) and transforming growth factor-b1 (TGF-b1) were assessed by immuno histochemistry. RESULTS: Left ventricular systolic end pressure and left ventricular developed pressure were significantly improved in the Sm+ group compared with the Sm-group. Pathological changes were ameliorated through significantly reduced TSP-1 and TGF-b1 protein levels. CONCLUSIONS: S. miltiorrhiza injection may improve the heart function of diabetic rats and protect against cardiomyopathy by downregulating TSP-1 and TGF-b1 in myocardial tissue.
Introduction
Diabetes is a worldwide epidemic, with an increasing number of diabetic patients facing the challenges of a variety of chronic complications. 1 Diabetic cardiomyopathy is increasingly recognized as a cause of J Yu, J Fei, J Azad et al. Diabetic rat myocardium protected by S. miltiorrhiza morbidity and mortality in patients with diabetes and in those with metabolic abnormalities such as hyperglycaemia, hyperinsulinaemia and hyperlipidaemia. 2 Diabetic cardiomyopathy may lead to myocardial fibrosis and/or myocardial hypertrophy by means of renin-angiotensin system activation, cardiac autonomic neuropathy and alterations in calcium homeostasis. 3 Transforming growth factor (TGF)-β1 is one of a group of potent regulatory cytokines that are involved in cellular processes including the production of fibroblasts, stimulation of intercellular matrix formation and hypertrophic cardiomyocyte growth. 4 TGF-β1 is also known to play a substantial role in fibrotic cardiac remodelling. 5 Hyperglycaemia stimulates angiotensin II accumulation, which induces TGF-β1 synthesis and activation. 5 The matrix glycoprotein thrombospondin-1 (TSP-1) is a primary regulator of enhanced TGF-β1 activation. 6 The effects of TSP-1 on endothelial cell migration are mediated by TGF-β1, whereas the effects of TSP-1 on fibroblast migration are TGF-β1independent. 7, 8 Thus, it is possible that increased activation of TSP-1 and TGF-β1 may exacerbate fibrotic complications in myocardial cells, under hyperlipidaemic conditions. 9, 10 Salvia miltiorrhiza is a traditional Chinese medicine that is widely used throughout clinics in eastern Asia to treat coronary heart disease, 11 unstable angina, 12, 13 cerebrovascular diseases 14 and diabetic vascular complications. 15 Biochemical and pharmacological investigation of S. miltiorrhiza has identified salvia miltiorrhizasu, tanshinone and phenolic acids as the compounds responsible for the beneficial pharmacological activities of this drug. 16, 17 The therapeutic effects of S. miltiorrhiza injection have been linked to antioxidant properties independent of blood pressure control, partially through the inhibition of reduced nicotinamide adenine dinucleotide phosphate oxidase. 18, 19 The underlying mechanism for the protective role of S. miltiorrhiza in diabetic cardiomyopathy remains unclear.
The present study investigated the myocardial protective effects of S. miltiorrhiza injection in experimental diabetic cardiomyopathy, and investigated the potential relationship between levels of TGFβ and TSP-1 protein in the heart and the protective effects of S. miltiorrhiza.
Materials and methods

ANIMAL MODEL INDUCTION
This study was conducted in the School of Medicine, Zhejiang University, Hangzhou, China, and conformed to the Guide for the Care and Use of Laboratory Animals, published by the National Academy of Sciences. 20 The investigation was approved by the Animal Care Committee of Zhejiang University, Hangzhou, China (No. 201005201).
Thirty male, 2-month-old Sprague-Dawley rats (Experiment Animal Centre of Zhejiang University, Hangzhou, China) were used in the experiments and were housed under a 12-h light/12-h dark cycle with free access to food and water. The rats were randomized according to a computergenerated randomization schedule into three groups (n = 10 per group) and fasted for 10 h. The groups were designated: diabetes, no treatment (Sm-); diabetes, S. miltiorrhiza injection (Sm+); control. To induce diabetes, each rat in the Sm-and Sm+ groups received a single dose of 65 mg/kg streptozotocin (STZ) (Alexis Corporation, Lausen, Switzerland) administered via intraperitoneal (i.p.) injection; each of the remaining 10 rats (control group) received J Yu, J Fei, J Azad et al. Diabetic rat myocardium protected by S. miltiorrhiza an i.p. injection of an equivalent volume of 0.9% saline. Before and 48 h after the injection of STZ or saline, blood glucose concentrations were measured in all animals using a MediSense ® Optium™ Blood Glucose Electrode (Abbot Laboratories, Abbott Park, IL, USA); a glucose concentration > 15 mM indicated the successful induction of diabetes. 21 The S. miltiorrhiza solution for injection used in the study was prepared by a water extraction and alcohol precipitation process that is commonly used in traditional Chinese medicine, and was supplied by Qinchunbao Pharmaceutical Corporation (Hangzhou, Zhejiang Province, China). Following the induction of diabetes, 48 h after STZ or saline injection, rats in the Sm+ group received 100 mg/kg per day S. miltiorrhiza via i.p. injection for 4 weeks; rats in the other two groups received the same volume of 0.9% saline via i.p. injection each day, for the same time period. Blood glucose concentrations were measured once weekly in all three groups, using the method described above.
DETERMINATION OF HEART FUNCTION
After 4 weeks' treatment, five rats from each group were sacrificed in order to determine heart function by Langendorff isolated in vivo heart perfusion. After stunning and cervical dislocation, the heart was immediately excised and mounted on a Langendorff apparatus (Radnoti LLC, Monrovia, CA, USA) for perfusion at 37°C with Krebs-Henseleit buffer (pH 7.4) at a constant pressure (76 mmHg). The left atrium was opened and a fluid-filled latex balloon was inserted into the left ventricle. The balloon was connected via a short plastic tube to a pressure transducer and computer. The heart was perfused for approximately 30 min. After perfusion for approximately 10 -20 min, left ventricular systolic end pressure (LVSEP) and left ventricular developed pressure (LVDP) were measured over a 5-min period.
HISTOPATHOLOGICAL AND IMMUNOHISTOCHEMICAL ANALYSES
Pathological changes of the myocardium were observed by haematoxylin and eosin staining; TSP-1 and TGF-β1 protein levels were assessed by 3,3′-diamino benzidine (DAB) immunohistochemistry. Five rats from each group were anaesthetized and perfused intracardially with normal saline (pH 7.0). Following saline perfusion, animals were perfused with 300 ml fixative containing 4% paraformaldehyde in 0.1 M phosphatebuffered saline (PBS; pH 7.4). After perfusion, the heart of each rat was removed, fixed in the same fixative for 4 h, then placed in 30% phosphate-buffered sucrose (pH 7.4) until the tissue sank. Tissue sections (10 µm) were cut on a freezing microtome through coronary planes of the heart and mounted onto 0.02% poly-L-lysine-coated slides.
For immunohistochemical staining, the Vectastain ABC system (Vector Laboratories, Burlingame, CA, USA) was used, with DAB as the chromagen. Briefly, tissue sections were washed in 0.1 M PBS and incubated in 1% bovine serum albumin (BSA) (pH 7.0) for 30 min. The tissues were then incubated overnight at 4°C with mouse antirat TSP-1 or antirat TGF-β1 monoclonal antibodies (1:100 dilution in 0.1 M PBS plus 1% BSA; Santa Cruz Biotechnology, Santa Cruz, CA, USA). Control sections were incubated in 0.1 M PBS plus 1% BSA. Sections were washed three times for 5 min in 0.1 M PBS, then incubated with a biotinylated goat antimouse secondary antibody (1:200 dilution; Boster Biological Technology, Wuhan, Hubei, China) for 5 h at room Diabetic rat myocardium protected by S. miltiorrhiza temperature. Sections were washed three times for 5 min in 0.1 M PBS, then incubated in an avidin-horseradish peroxidase solution according to the kit manufacturer's instructions.
Immunolabelling was visualized with 0.05% DAB plus 0.3% hydrogen peroxide in PBS. The sections were then dehydrated through ethanol and xylene before cover slips were applied.
Slides of the left ventricular myocardium in each rat were examined at × 400 magnification and analysed with UTHSCSA ImageTool 3.0 (University of Texas Health Science Center at San Antonio, TX, USA). The numbers of TSP-1-and TGF-β1-positive cells per mm 2 were counted.
STATISTICAL ANALYSES
All data were presented as mean ± SD. Statistical analyses were performed using SPSS ® statistical software, version 12.0 (SPSS Inc., Chicago, IL, USA) for Windows ® . Differences in body weight and blood glucose levels between treatment groups were evaluated using a two-sample Student's t-test. All other data were evaluated using oneway analysis of variance. A P-value < 0.05 was considered to be statistically significant.
Results
Induction of diabetes was successful in all 10 rats in the SM+ and SM-groups. Before STZ injection, there was no significant difference among the three groups with regard to body weight or blood glucose concentrations (data not shown). After 4 weeks' S. miltiorrhiza treatment, the Sm+ group had a significantly higher body weight and significantly lower blood glucose concentration compared with the untreated Sm-group; both groups had significantly lower body weights and higher blood glucose concentrations than the control group (P < 0.01 for all comparisons; Fig. 1 ).
After 4 weeks' S. miltiorrhiza treatment, rats in the Sm+ group had a significantly higher LVSEP and a significantly lower LVDP compared with the untreated Sm-group; both groups had significantly lower LVSEP and higher LVDP than the control group (P < 0.01 for all comparisons; Fig. 2 ). 
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Histopathology of myocardial tissue showed that, compared with rats in the control group (Fig. 3A) , rats in the Sm-group had hypertrophy and interstitial fibrosis to varying degrees, with structural rarefaction (Fig. 3B) . Rats in the Sm+ group showed less hypertrophy and interstitial fibrosis (Fig. 3C ).
Myocardial tissue that was positive for TSP-1 and TGF-β protein showed cells with buffy granules. The myocardial cells, extracellular matrix (ECM) and the endothelial cells of the small vessels between myocardial cells all showed increased levels of TSP-1 and TGF-β1 in diabetic rats, compared with control rats (Fig. 4) . Quantitative analysis demonstrated a significant decrease in TSP-1-and TGF-β1positive cells in the Sm+ group compared with the Sm-group; both groups showed significant increases in TSP-1 and TGF-β1, compared with the control group (P < 0.05 for all comparisons; Fig. 5 ).
Discussion
Pharmacological research has shown that S. miltiorrhiza can activate blood and eliminate stasis, improve the microcirculation and inhibit aldose reductase activity. 22 Research has also shown that S. miltiorrhiza hydrophilic extract effectively reverses upregulation of vascular endothelial growth factor, induced by high glucose concentrations, by ameliorating mito chondrial oxidative stress. 23 S. miltiorrhiza hydrophilic extract is potentially an effective antioxidant therapy for treatment of the chronic vascular complications associated with diabetes, 23, 24 and has been shown to have clinical applications in the treatment of angina, 11 myocardial infarction 12 and coronary heart disease. 25 Diabetic cardiomyopathy is the most dangerous complication facing patients with diabetes and is characterized by myocardial hypertrophy, impairment of contractile proteins, accumulation of ECM proteins, formation of advanced glycation end products and decreased left ventricular compliance. 26 It has been suggested that the accumulation of ECM proteins (in particular collagen fibres) may have an important role in the pathological changes associated with diabetic cardiomyopathy. 27 The present study showed that the classical features of diabetes (including disorder and collapse of diabetic cardiac muscle fibres, decreases in heart function and elevated blood glucose concentrations) were successfully induced in STZ-treated rats. Diabetic rats treated with S. miltiorrhiza showed less myocardial hypertrophy and interstitial fibrosis (and had fewer diabetesinduced changes in blood glucose concentration, LVSEP and LVDP) compared with untreated diabetic rats. Thrombospondin-1 is a major component of platelet α-granules and the gene that encodes TSP-1 acts as an immediate-early response gene, being rapidly upregulated in response to serum and growth factors such as TGF-β1 and platelet-derived growth factor. 28 Experiments with rats have indicated that concentrations of TSP-1 and TGF-β1 are significantly higher in diabetic animals than in nondiabetic animals, and that diabetic animals have greater concentrations of collagen in myocardial interstitial tissue compared with nondiabetic animals. 29 Another study has confirmed that glucoseinduced activation of TGF-β1 is dependent on protein kinase C (PKC) activity, leading to a sequential increase in TSP-1 synthesis in cultured human mesangial cells; this suggests that high-glucose conditions may induce an increase in activity of the PKC-TGF-β-TSP-1 system. 30, 31 The present study showed that diabetes leads to upregulation of TSP-1 in the diabetic myocardium, and that i.p. injection of S. miltiorrhiza may decrease TSP-1 and TGF-β1, under hyperglycaemic conditions.
In conclusion, the present study showed that diabetes induced in rats leads to the upregulation of TSP-1 and TGF-β1 in the myocardium, and that such effects may be prevented by i.p. injection of S. miltiorrhiza. It is possible that S. miltiorrhiza injection may prevent progression to myocardial injury in diabetic rats by decreasing TSP-1 and TGF-β1 protein levels and interrupting the development of diabetic cardiomyopathy.
FIGURE 5:
Cell density of myocardial cells staining immunohistochemically positive for thrombospondin-1 (TSP-1) and transforming growth factor-β1 (TGF-β1) in adult male Sprague-Dawley rats (n = 10 per group), 4 weeks after 65 mg/kg streptozotocin was injected via intraperitoneal (i.p.) injection to induce diabetes (Sm+ and Smgroups); the third (control) group received an equal volume of 0.9% saline via i.p. injection. Diabetic rats then received either 100 mg/kg per day Salvia miltiorrhiza via i.p. injection for 4 weeks (Sm+ group) or no S. miltiorrhiza injection (Sm-group). Data presented as mean ± SD; a P < 0.05 compared with control group; b P < 0.05 compared with Sm-group 
